PT - JOURNAL ARTICLE AU - Sonia L. Taneja AU - Monica Passi AU - Sumona Bhattacharya AU - Samuel A. Schueler AU - Sandeep Gurram AU - Christopher Koh TI - COVID-19: An analysis of social media and research publication activity during the early stages of the pandemic AID - 10.1101/2020.12.20.20248517 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.20.20248517 4099 - http://medrxiv.org/content/early/2020/12/22/2020.12.20.20248517.short 4100 - http://medrxiv.org/content/early/2020/12/22/2020.12.20.20248517.full AB - Objectives The COVID-19 pandemic has highlighted the importance of rapid dissemination of scientific and medical discovery. Social media (SoMe) has become an invaluable platform in science and medicine. This study analyzed activity of SoMe (Twitter), preprints, and publications related to COVID-19 and gastroenterology (GI) during the COVID-19 pandemic.Methods Data from Twitter, preprint servers and PubMed was collected and analyzed from December 2019 through May 2020. Global and regional geographic and gastrointestinal organ specific social media trends were compared to preprint and publication activity; any associations were identified.Results Over the 6-month period, there were 73,079 tweets from 44,609 users, 7,164 publications, and 4,702 preprints. Twitter activity peaked during March while preprints and publications peaked in April 2020. Strong correlations were identified between Twitter and both preprints and publications activity (p<0.001 for both). While COVID-19 data across the 3 platforms concentrated on pulmonology/critical care, the majority of GI tweets pertained to pancreatology, most publications focused on hepatology, and most preprints covered hepatology and luminal GI (LGI). There were significant associations between Twitter activity and research for all GI subfields (p=0.009 for LGI, p=0.006 for hepatology and IBD, p=0.007 for endoscopy), except pancreatology (p=0.2). Twitter activity was highest in the US (7,331 tweets) whereas PubMed activity was highest in China (1,768 publications).Conclusions The COVID-19 pandemic has highlighted the utility of SoMe as a vehicle for disseminating scientific information during a public health crisis. Scientists and clinicians should consider the use of SoMe in augmenting public awareness of their scholarly pursuits.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding support was provided by Intramural Research Programs, National Institute of Digestive, Diabetes, and Kidney Disease.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is a retrospective analysis of publicly available data without use of human subjects and therefore is IRB-exempt.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript and note links is publicly available. https://www.symplur.com https://www.biorxiv.org/ https://pubmed.ncbi.nlm.nih.gov/ https://www.twitter.com (COVID-19)coronavirus disease 2019(GI)gastroenterology(HCSM)healthcare social media(IBD)inflammatory bowel disease(LGI)luminal gastroenterology(SARS-CoV-2)severe acute respiratory syndrome coronavirus 2(SoMe)social media(US)United States(UK)United Kingdom